Cargando…
mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance
Insulin resistance (IR) and microRNAs (miRNAs), which regulate cell-to-cell communication between hepatocytes and hepatic stellate cells (HSCs), may intertwine in nonalcoholic fatty liver disease (NAFLD) pathogenesis. The aim of this study was to evaluate whether epigenetics and environmental factor...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893471/ https://www.ncbi.nlm.nih.gov/pubmed/31671785 http://dx.doi.org/10.3390/nu11112597 |
_version_ | 1783476206908211200 |
---|---|
author | Meroni, Marica Longo, Miriam Erconi, Veronica Valenti, Luca Gatti, Stefano Fracanzani, Anna Ludovica Dongiovanni, Paola |
author_facet | Meroni, Marica Longo, Miriam Erconi, Veronica Valenti, Luca Gatti, Stefano Fracanzani, Anna Ludovica Dongiovanni, Paola |
author_sort | Meroni, Marica |
collection | PubMed |
description | Insulin resistance (IR) and microRNAs (miRNAs), which regulate cell-to-cell communication between hepatocytes and hepatic stellate cells (HSCs), may intertwine in nonalcoholic fatty liver disease (NAFLD) pathogenesis. The aim of this study was to evaluate whether epigenetics and environmental factors interact to promote progressive NAFLD during IR. We examined the miRNA signature in insulin receptor haploinsufficient (InsR+/−) and wild-type (wt) HSCs by RNAseq (n = 4 per group). Then, we evaluated their impact in an IR-NASH (nonalcoholic steatohepatitis) model (InsR+/− mice fed standard or methionine choline deficient (MCD) diet, n = 10 per group) and in vitro. InsR+/− HSCs displayed 36 differentially expressed miRNAs (p < 0.05 vs. wt), whose expression was then analyzed in the liver of InsR+/− mice fed an MCD diet. We found that miR-101-3p negatively associated with both InsR+/− genotype and MCD (p < 0.05) and the histological spectrum of liver damage (p < 0.01). miR-101-3p was reduced in InsR+/− hepatocytes and HSCs and even more in InsR+/− cells exposed to insulin (0.33 µM) and fatty acids (0.25 mM), resembling the IR-NASH model. Conversely, insulin induced miR-101-3p expression in wt cells but not in InsR+/− ones (p < 0.05). In conclusion, IR combined with diet-induced liver injury favors miR-101-3p downregulation, which may promote progressive NAFLD through HSC and hepatocyte transdifferentiation and proliferation. |
format | Online Article Text |
id | pubmed-6893471 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-68934712019-12-23 mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance Meroni, Marica Longo, Miriam Erconi, Veronica Valenti, Luca Gatti, Stefano Fracanzani, Anna Ludovica Dongiovanni, Paola Nutrients Article Insulin resistance (IR) and microRNAs (miRNAs), which regulate cell-to-cell communication between hepatocytes and hepatic stellate cells (HSCs), may intertwine in nonalcoholic fatty liver disease (NAFLD) pathogenesis. The aim of this study was to evaluate whether epigenetics and environmental factors interact to promote progressive NAFLD during IR. We examined the miRNA signature in insulin receptor haploinsufficient (InsR+/−) and wild-type (wt) HSCs by RNAseq (n = 4 per group). Then, we evaluated their impact in an IR-NASH (nonalcoholic steatohepatitis) model (InsR+/− mice fed standard or methionine choline deficient (MCD) diet, n = 10 per group) and in vitro. InsR+/− HSCs displayed 36 differentially expressed miRNAs (p < 0.05 vs. wt), whose expression was then analyzed in the liver of InsR+/− mice fed an MCD diet. We found that miR-101-3p negatively associated with both InsR+/− genotype and MCD (p < 0.05) and the histological spectrum of liver damage (p < 0.01). miR-101-3p was reduced in InsR+/− hepatocytes and HSCs and even more in InsR+/− cells exposed to insulin (0.33 µM) and fatty acids (0.25 mM), resembling the IR-NASH model. Conversely, insulin induced miR-101-3p expression in wt cells but not in InsR+/− ones (p < 0.05). In conclusion, IR combined with diet-induced liver injury favors miR-101-3p downregulation, which may promote progressive NAFLD through HSC and hepatocyte transdifferentiation and proliferation. MDPI 2019-10-29 /pmc/articles/PMC6893471/ /pubmed/31671785 http://dx.doi.org/10.3390/nu11112597 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Meroni, Marica Longo, Miriam Erconi, Veronica Valenti, Luca Gatti, Stefano Fracanzani, Anna Ludovica Dongiovanni, Paola mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance |
title | mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance |
title_full | mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance |
title_fullStr | mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance |
title_full_unstemmed | mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance |
title_short | mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance |
title_sort | mir-101-3p downregulation promotes fibrogenesis by facilitating hepatic stellate cell transdifferentiation during insulin resistance |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6893471/ https://www.ncbi.nlm.nih.gov/pubmed/31671785 http://dx.doi.org/10.3390/nu11112597 |
work_keys_str_mv | AT meronimarica mir1013pdownregulationpromotesfibrogenesisbyfacilitatinghepaticstellatecelltransdifferentiationduringinsulinresistance AT longomiriam mir1013pdownregulationpromotesfibrogenesisbyfacilitatinghepaticstellatecelltransdifferentiationduringinsulinresistance AT erconiveronica mir1013pdownregulationpromotesfibrogenesisbyfacilitatinghepaticstellatecelltransdifferentiationduringinsulinresistance AT valentiluca mir1013pdownregulationpromotesfibrogenesisbyfacilitatinghepaticstellatecelltransdifferentiationduringinsulinresistance AT gattistefano mir1013pdownregulationpromotesfibrogenesisbyfacilitatinghepaticstellatecelltransdifferentiationduringinsulinresistance AT fracanzaniannaludovica mir1013pdownregulationpromotesfibrogenesisbyfacilitatinghepaticstellatecelltransdifferentiationduringinsulinresistance AT dongiovannipaola mir1013pdownregulationpromotesfibrogenesisbyfacilitatinghepaticstellatecelltransdifferentiationduringinsulinresistance |